​

Adaptive Bio (ADPT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Adaptive Bio Revenue Highlights

Latest Revenue (Y)

$170.28M

Latest Revenue (Q)

$46.44M

Main Segment (Y)

Sequencing Revenue

Adaptive Bio Revenue by Period

Adaptive Bio Revenue by Year

DateRevenueChange
2023-12-31$170.28M-8.11%
2022-12-31$185.31M20.06%
2021-12-31$154.34M56.88%
2020-12-31$98.38M15.65%
2019-12-31$85.07M52.83%
2018-12-31$55.66M44.77%
2017-12-31$38.45M-

Adaptive Bio generated $170.28M in revenue during NA 2023, up -8.11% compared to the previous quarter, and up 305.91% compared to the same period a year ago.

Adaptive Bio Revenue by Quarter

DateRevenueChange
2024-09-30$46.44M7.51%
2024-06-30$43.19M3.15%
2024-03-31$41.87M-8.54%
2023-12-31$45.78M20.74%
2023-09-30$37.92M-22.50%
2023-06-30$48.93M29.96%
2023-03-31$37.65M-31.80%
2022-12-31$55.20M15.40%
2022-09-30$47.83M9.55%
2022-06-30$43.66M13.05%
2022-03-31$38.62M1.82%
2021-12-31$37.93M-3.89%
2021-09-30$39.47M2.50%
2021-06-30$38.51M0.16%
2021-03-31$38.44M27.35%
2020-12-31$30.18M14.78%
2020-09-30$26.30M25.30%
2020-06-30$20.99M0.37%
2020-03-31$20.91M-13.63%
2019-12-31$24.21M-7.10%
2019-09-30$26.06M17.71%
2019-06-30$22.14M74.78%
2019-03-31$12.67M-26.33%
2018-12-31$17.19M0.02%
2018-09-30$17.19M48.58%
2018-06-30$11.57M19.07%
2018-03-31$9.71M-

Adaptive Bio generated $46.44M in revenue during Q3 2024, up 7.51% compared to the previous quarter, and up 94.91% compared to the same period a year ago.

Adaptive Bio Revenue Breakdown

Adaptive Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20Dec 19
Sequencing Revenue$78.90M$41.44M$43.52M
Development Revenue Regulatory Milestones$10.00M$2.50M$2.00M
Development Support Revenue$65.45M$54.44M$39.55M
Development Revenue-$56.94M$41.55M

Adaptive Bio's latest annual revenue breakdown by segment (product or service), as of Dec 21: Sequencing Revenue (51.12%), Development Support Revenue (42.40%), and Development Revenue Regulatory Milestones (6.48%).

Quarterly Revenue by Product

Product/ServiceDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Medicare Revenue$500.00K$1.40M$500.00K--------
Development Revenue---$23.27M$17.48M$15.02M$13.00M$11.44M---
Sequencing Revenue---$15.17M$12.71M$11.28M$7.99M$9.47M$13.89M$11.68M$11.87M
Sequencing Revenue From Coverage Policy--------$500.00K$300.00K$300.00K
Sequencing Revenue From Test Deliver---------$100.00K$100.00K

Adaptive Bio's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: Medicare Revenue (100.00%).

Adaptive Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RPRXRoyalty Pharma$2.35B$564.69M
BEAMBeam Therapeutics$377.71M$14.27M
APLSApellis Pharmaceuticals$366.28M$176.57M
LEGNLegend Biotech$285.14M$93.99M
ADPTAdaptive Bio$170.28M$46.44M
VIRVir Bio$86.18M$2.38M
KRYSKrystal Biotech$50.70M$83.84M
CRBUCaribou Biosciences$34.48M$3.46M
VERVVerve Therapeutics$11.76M$6.87M
IKNAIkena Oncology$9.16M-
ZURAZura Bio--
SANASana Bio--
HEPAHepion Pharmaceuticals--
ELEVElevation Oncology--
ENVBEnveric Biosciences--

ADPT Revenue FAQ

What is Adaptive Bio’s yearly revenue?

Adaptive Bio's yearly revenue for 2023 was $170.28M, representing a decrease of -8.11% compared to 2022. The company's yearly revenue for 2022 was $185.31M, representing an increase of 20.06% compared to 2021. ADPT's yearly revenue for 2021 was $154.34M, representing an increase of 56.88% compared to 2020.

What is Adaptive Bio’s quarterly revenue?

Adaptive Bio's quarterly revenue for Q3 2024 was $46.44M, a 7.51% increase from the previous quarter (Q2 2024), and a 22.46% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $43.19M, a 3.15% increase from the previous quarter (Q1 2024), and a -11.72% decrease year-over-year (Q2 2023). ADPT's quarterly revenue for Q1 2024 was $41.87M, a -8.54% decrease from the previous quarter (Q4 2023), and a 11.23% increase year-over-year (Q1 2023).

What is Adaptive Bio’s revenue growth rate?

Adaptive Bio's revenue growth rate for the last 3 years (2021-2023) was 10.32%, and for the last 5 years (2019-2023) was 100.16%.

What are Adaptive Bio’s revenue streams?

Adaptive Bio's revenue streams in c 21 are Sequencing Revenue, Development Revenue Regulatory Milestones, and Development Support Revenue. Sequencing Revenue generated $78.9M in revenue, accounting 51.12% of the company's total revenue, up 90.39% year-over-year. Development Revenue Regulatory Milestones generated $10M in revenue, accounting 6.48% of the company's total revenue, up 300.00% year-over-year. Development Support Revenue generated $65.45M in revenue, accounting 42.40% of the company's total revenue, up 20.21% year-over-year.

What is Adaptive Bio’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Adaptive Bio was Sequencing Revenue. This segment made a revenue of $78.9M, representing 51.12% of the company's total revenue.